Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015-2019: A content analysis

James Larkin, Britta Matthes, Mohamed Azribi, Conor Kearns, Shai Mulinari, Emily Rickard, Frank Moriarty, Tom Fahey, Piotr Ozieranski
doi: https://doi.org/10.1101/2024.04.12.24305382

Article Information

doi 
https://doi.org/10.1101/2024.04.12.24305382
History 
  • April 15, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Dr. James Larkin1,*,
  2. Dr. Britta Matthes2,
  3. Mohamed Azribi3,
  4. Conor Kearns3,
  5. Dr. Shai Mulinari4,
  6. Emily Rickard5,
  7. Dr. Frank Moriarty6,
  8. Prof. Tom Fahey1 and
  9. Dr. Piotr Ozieranski5
  1. 1Department of General Practice, RCSI University of Medicine and Health Sciences, Dublin, Ireland
  2. 2Department for Health, University of Bath, Bath, UK
  3. 3School of Medicine, RCSI University of Medicine and Health Sciences, Dublin 2, Ireland
  4. 4Department of Sociology, Lund University, Lund, Sweden
  5. 5Department of Social and Policy Sciences, Centre for the Analysis of Social Policy, University of Bath, Bath, UK
  6. 6School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland
  1. ↵*Larkinja{at}tcd.ie
Back to top
Posted April 15, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015-2019: A content analysis
James Larkin, Britta Matthes, Mohamed Azribi, Conor Kearns, Shai Mulinari, Emily Rickard, Frank Moriarty, Tom Fahey, Piotr Ozieranski
medRxiv 2024.04.12.24305382; doi: https://doi.org/10.1101/2024.04.12.24305382
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area